Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, Guangdong, China.
Wadsworth Center, New York State Department of Health, Albany, NY, 12201-0509, USA.
Anal Bioanal Chem. 2018 Sep;410(24):6257-6267. doi: 10.1007/s00216-018-1236-y. Epub 2018 Jul 14.
A candidate reference measurement procedure (RMP) for measurement of unconjugated estriol in human serum has been developed and validated. The proposed method is highly reliable and uses isotope dilution coupled with liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS) and requires no derivatization. An appropriate amount of serum was accurately weighed and spiked with an isotopically labeled internal standard. Unconjugated estriol and its internal standard were extracted from serum matrix using liquid-liquid extraction prior to reversed-phase LC-MS/MS. Calibrator bracketing was used to give higher specificity and accuracy for assigning serum level. The accuracy of the candidate RMP was validated by split-sample comparison to established RMPs. The lowest limit of detection (LLoD) and lowest limit of quantification (LLoQ) for developed RMP was estimated to be 0.14 nmol/L and 0.35 nmol/L, respectively. Both intra- and inter-assay imprecisions were ≤2.19% at 1.39, 17.34 and 69.35 nmol/L, respectively. Recoveries were 98.54% to 100.34% and linear response ranged from 0.35 to 173.38 nmol/L. No interference was observed. Biases were 5.6% and 2.8% against the targets of RELA2015A (3.87 nmol/L) and RELA2015B (40.62 nmol/L), respectively. Moreover, the candidate RMP was successfully applied to measure level of unconjugated estriol in serum samples of pregnant women (n = 3) and compared with two immunoassays in clinical laboratory. Our developed method is simple, accurate, and can be used as a candidate RMP to determine total unconjugated estriol level in human serum. Further improvement of certain immunoassays in accuracy and precision is needed. Graphical abstract Selected ion chromatograms by LC-MS/MS using a C18 column for uE from a serum sample.
已开发并验证了一种用于测量人血清中未结合雌三醇的候选参考测量程序(RMP)。所提出的方法非常可靠,使用同位素稀释结合液相色谱-串联质谱法(ID-LC-MS/MS),且无需衍生化。准确称量适量血清,并加入同位素标记的内标。在反相 LC-MS/MS 之前,使用液液萃取从血清基质中提取未结合雌三醇及其内标。使用校准器夹心法可提高血清水平赋值的特异性和准确性。通过与已建立的 RMP 进行拆分样本比较来验证候选 RMP 的准确性。所开发的 RMP 的最低检测限(LLOQ)和最低定量限(LLOQ)分别估计为 0.14 nmol/L 和 0.35 nmol/L。在 1.39、17.34 和 69.35 nmol/L 时,内和日间精密度均≤2.19%。回收率为 98.54%至 100.34%,线性响应范围为 0.35 至 173.38 nmol/L。未观察到干扰。与 RELA2015A(3.87 nmol/L)和 RELA2015B(40.62 nmol/L)的目标相比,偏差分别为 5.6%和 2.8%。此外,候选 RMP 成功应用于测量孕妇(n=3)血清样品中的未结合雌三醇水平,并与临床实验室中的两种免疫测定法进行了比较。我们开发的方法简单、准确,可作为候选 RMP 用于确定人血清中总未结合雌三醇的水平。需要进一步提高某些免疫测定法的准确性和精密度。